Projects

For iGEM 2024, our project is Synthesized Heparin. [Wiki coming soon]

Why: To revolutionize Heparin production, ensuring consistent, safe, and sustainable sourcing, advancing patient care in critical medical scenarios.

How: By synthesizing Heparin in E. coli through the expression of key enzymes, leveraging a certain precursor and the BioBrick system/multiple plasmids.

What: Highly pure, standardized Heparin, biosynthesized in E. coli, offering improved safety, efficacy, and sustainability, with reduced variability and dependency on fluctuating markets.

---

Our innovative approach harnesses the power of biotechnology to synthesize Heparin in E. coli, ensuring unparalleled purity and consistency. By eliminating the reliance on pig gut extraction, we provide a sustainable and reliable source of Heparin, free from contamination and market fluctuations. Optimizing dosage management and enhancing safety measures, our biosynthesized Heparin offers a revolutionary solution for critical medical scenarios, empowering healthcare providers and instilling confidence in patients worldwide.